Trial Profile
Effect of a New Potent Acid Inhibitory Drug, Vonoprazan on Healing Rate of Peptic Ulcers
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2020
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Duodenal ulcer; Gastric ulcer; Peptic ulcer
- Focus Therapeutic Use
- 28 Dec 2017 New trial record